![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 31, 19691-19698, July 31, 1998
From the The determinants of insulin-like growth factor
(IGF) binding to its binding proteins (IGFBPs) are poorly characterized
in terms of important residues in the IGFBP molecule. We have
previously used tyrosine iodination to implicate Tyr-60 in the
IGF-binding site of bovine IGFBP-2 (Hobba, G. D., Forbes, B. E., Parkinson, E. J., Francis, G. L., and Wallace, J. C. (1996) J. Biol. Chem. 271, 30529-30536). In this
report, we show that the mutagenic replacement of Tyr-60 with either
Ala or Phe reduced the affinity of bIGFBP-2 for IGF-I (4.0- and
8.4-fold, respectively) and for IGF-II (3.5- and 4.0-fold,
respectively). Although adjacent residues Val-59, Thr-61, Pro-62, and
Arg-63 are well conserved in IGFBP family members, Ala substitution for
these residues did not reduce the IGF affinity of bIGFBP-2. Kinetic
analysis of the bIGFBP-2 mutants on IGF biosensor chips in the BIAcore
instrument revealed that Tyr-60
Alanine Screening Mutagenesis Establishes Tyrosine 60 of Bovine
Insulin-like Growth Factor Binding Protein-2 as a Determinant of
Insulin-like Growth Factor Binding
§,
,
,
§,
**, and
§
Cooperative Research Centre for Tissue
Growth and Repair,
Pharmacia & Upjohn AB, Metabolic Diseases Research,
S112 87 Stockholm, Sweden
Phe bIGFBP-2 bound to the IGF-I
surface 3.0-fold more slowly than bIGFBP-2 and was released 2.6-fold
more rapidly than bIGFBP-2. We therefore propose that the hydroxyl
group of Tyr-60 participates in a hydrogen bond that is important for
the initial complex formation with IGF-I and the stabilization of this
complex. In contrast, Tyr-60
Ala bIGFBP-2 associated with the IGF-I
surface 5.0-fold more rapidly than bIGFBP-2 but exhibited an 18.4-fold
more rapid release from this surface compared with bIGFBP-2. Thus both
the aromatic nature and the hydrogen bonding potential of the tyrosyl
side chain of Tyr-60 are important structural determinants of the
IGF-binding site of bIGFBP-2.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Denley, C. C. Wang, K. A. McNeil, M. J. E. Walenkamp, H. van Duyvenvoorde, J. M. Wit, J. C. Wallace, R. S. Norton, M. Karperien, and B. E. Forbes Structural and Functional Characteristics of the Val44Met Insulin-Like Growth Factor I Missense Mutation: Correlation with Effects on Growth and Development Mol. Endocrinol., March 1, 2005; 19(3): 711 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beattie, K. Phillips, J. H Shand, M. Szymanowska, D. J Flint, and G. J Allan Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis J. Mol. Endocrinol., February 1, 2005; 34(1): 163 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Shand, J. Beattie, H. Song, K. Phillips, S. M. Kelly, D. J. Flint, and G. J. Allan Specific Amino Acid Substitutions Determine the Differential Contribution of the N- and C-terminal Domains of Insulin-like Growth Factor (IGF)-binding Protein-5 in Binding IGF-I J. Biol. Chem., May 9, 2003; 278(20): 17859 - 17866. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Giri, S. Linse, P. G. de Frutos, T. Yamazaki, B. O. Villoutreix, and B. Dahlback Structural Requirements of Anticoagulant Protein S for Its Binding to the Complement Regulator C4b-binding Protein J. Biol. Chem., April 19, 2002; 277(17): 15099 - 15106. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Vilmos, K Gaudenz, Z Hegedus, and J L Marsh The Twisted gastrulation family of proteins, together with the IGFBP and CCN families, comprise the TIC superfamily of cysteine rich secreted factors Mol. Pathol., October 1, 2001; 54(5): 317 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Baxter Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E967 - E976. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Duan, J. Ding, Q. Li, W. Tsai, and K. Pozios Insulin-like growth factor binding protein 2 is a growth inhibitory protein conserved in zebrafish PNAS, December 21, 1999; 96(26): 15274 - 15279. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hwa, Y. Oh, and R. G. Rosenfeld The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily Endocr. Rev., December 1, 1999; 20(6): 761 - 787. [Abstract] [Full Text] |
||||
![]() |
F. E. Carrick, B. E. Forbes, and J. C. Wallace BIAcore Analysis of Bovine Insulin-like Growth Factor (IGF)-binding Protein-2 Identifies Major IGF Binding Site Determinants in Both the Amino- and Carboxyl-terminal Domains J. Biol. Chem., July 13, 2001; 276(29): 27120 - 27128. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |